KRAS mutation subtypes have different co-occurring mutations and a distinct genomic landscape. The clinical relevance of these differences in the context of specific therapeutic interventions w
Summary This metadata record provides details of the data supporting the claims of the related manuscript: “Inflation of Tumor Mutation Burden by Tumor-Only Sequencing in Under-Represented
